Philip Morris International Inc.

WBAG:PMOR Stock Report

Market Cap: €189.9b

Philip Morris International Valuation

Is PMOR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PMOR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PMOR (€122.66) is trading below our estimate of fair value (€242.88)

Significantly Below Fair Value: PMOR is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PMOR?

Key metric: As PMOR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PMOR. This is calculated by dividing PMOR's market cap by their current earnings.
What is PMOR's PE Ratio?
PE Ratio20.9x
EarningsUS$9.81b
Market CapUS$199.94b

Price to Earnings Ratio vs Peers

How does PMOR's PE Ratio compare to its peers?

The above table shows the PE ratio for PMOR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average15.7x
MO Altria Group
9.3x-4.7%US$94.8b
ITC ITC
28.5x9.6%₹5.8t
2914 Japan Tobacco
15.4x5.6%JP¥7.4t
IMB Imperial Brands
9.6x0.8%UK£20.0b
PMOR Philip Morris International
20.9x9.4%€199.9b

Price-To-Earnings vs Peers: PMOR is expensive based on its Price-To-Earnings Ratio (20.9x) compared to the peer average (15.7x).

Price to Earnings Ratio vs Industry

How does PMOR's PE Ratio compare vs other companies in the Global Tobacco Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PMOR 20.9xIndustry Avg. 11.7xNo. of Companies8PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PMOR is expensive based on its Price-To-Earnings Ratio (20.9x) compared to the Global Tobacco industry average (11.9x).

Price to Earnings Ratio vs Fair Ratio

What is PMOR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PMOR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PMOR's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PMOR forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€122.66
€125.04
+1.9%
12.1%€142.51€93.78n/a13
Nov ’25€121.14
€123.51
+2.0%
12.5%€142.72€93.92n/a13
Oct ’25€109.90
€114.26
+4.0%
11.3%€130.99€92.15n/a13
Sep ’25€110.94
€107.78
-2.8%
9.1%€121.65€86.24n/a14
Aug ’25€107.66
€106.76
-0.8%
8.6%€123.64€87.66n/a14
Jul ’25€95.07
€103.53
+8.9%
8.3%€124.79€83.82n/a14
Jun ’25€92.59
€101.84
+10.0%
9.0%€124.71€80.04n/a15
May ’25€88.52
€102.25
+15.5%
8.8%€125.53€80.56n/a16
Apr ’25€85.25
€99.34
+16.5%
9.5%€123.33€78.23n/a15
Mar ’25€82.55
€98.98
+19.9%
10.4%€124.37€78.89n/a16
Feb ’25€84.90
€99.55
+17.3%
10.7%€123.44€78.76n/a16
Jan ’25€84.95
€99.42
+17.0%
9.1%€119.08€78.32n/a18
Dec ’24€85.45
€99.37
+16.3%
9.1%€118.48€77.92n/a18
Nov ’24€84.15
€103.25
+22.7%
8.6%€122.45€80.53€121.1417
Oct ’24€88.50
€107.39
+21.4%
7.7%€123.08€82.37€109.9017
Sep ’24€88.45
€104.24
+17.8%
8.2%€119.86€80.21€110.9418
Aug ’24€89.85
€101.73
+13.2%
8.2%€116.86€78.20€107.6618
Jul ’24€89.60
€103.45
+15.5%
8.2%€119.13€79.73€95.0718
Jun ’24€84.15
€102.76
+22.1%
8.0%€118.11€81.77€92.5918
May ’24€90.55
€102.48
+13.2%
7.9%€117.66€81.46€88.5218
Apr ’24€89.36
€104.41
+16.8%
8.2%€119.93€83.03€85.2517
Mar ’24€91.25
€104.95
+15.0%
8.6%€121.93€84.41€82.5519
Feb ’24€95.77
€98.09
+2.4%
10.0%€118.34€81.93€84.9019
Jan ’24€94.60
€98.86
+4.5%
10.2%€119.81€81.13€84.9518
Dec ’23€96.41
€99.36
+3.1%
9.5%€122.91€83.23€85.4517
Nov ’23€92.59
€102.72
+10.9%
10.2%€128.77€86.18€84.1517

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Altria Group

US$94.8b

Through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States.

ALTR

US$53.22

7D

4.8%

1Y

42.7%

Keurig Dr Pepper

US$42.9b

Owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally.

KDP

US$29.67

7D

-4.5%

1Y

2.0%

Südzucker

€2.3b

Produces and sells sugar products in Germany, rest of the European Union, the United Kingdom, the United States, and internationally.

SZU

€11.08

7D

-1.6%

1Y

-24.6%